8000 Aarhus, Denmark Clinical Trials

A listing of 8000 Aarhus, Denmark clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 395 clinical trials
featured
An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Aarhus University Hospital
 (0.5 away) Contact site
  • 780 views
  • 25 Mar, 2021
  • +29 other locations
Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years

This study evaluates the effect of different induction courses in children and adolescents with newly diagnosed acute myeloid leukemia. In the first course patients are randomised to receive either standard anthracycline therapy with mitoxantrone or experimental DaunoXome. In the second course patients are randomised between standard treatment with ADxE (cytarabine, …

Department of Pediatrics, Aarhus University Hospital Skejby
 (4.0 away) Contact site
  • 26 views
  • 21 Jan, 2021
  • +32 other locations
An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma

The overall aim of this project is to improve the outcome of patients diagnosed with ependymoma by improving and harmonising the staging and the standard of care of this patient population and to improve the investigators understanding of the underlying biology thereby informing future treatment. The program will evaluate new …

Aarhus University Hospital
 (4.0 away) Contact site
  • 25 views
  • 24 Jan, 2021
  • +61 other locations
Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis

This study is testing whether stratification of the patients according to biological risk factors for different treatment groups will improve the outcome of patients with clinically high diffuse large B-cell lymphoma (DLBCL).

burkitt's lymphoma
t-cell lymphoma
large cell lymphoma
follicular lymphoma
transformed lymphoma
Aarhus University Hospital
 (1.2 away) Contact site
  • 32 views
  • 23 Jan, 2021
  • +17 other locations
The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.

The aim of this study is to investigate the importance of clinical characterization of children with monosymptomatic nocturnal enuresis (MNE) in order to improve treatment efficacy. The hypothesis is that clinical characterization by measurement of nocturnal urine production and maximal voided volumes in children with MNE and subsequent treatment tailoring …

Aarhus University Hospital
 (4.0 away) Contact site
  • 17 views
  • 25 Jan, 2021
  • +6 other locations
European Low and Intermediate Risk Neuroblastoma Protocol

The European study, LINES 2009 (Low and Intermediate Risk Neuroblastoma European Study), groups together in a single protocol the treatment of all patients with "non high risk" neuroblastoma (NB), with stratification into two groups: low risk and intermediate risk. These two separate cohorts are included in one single protocol to …

Aarhus University Hospital
 (1.2 away) Contact site
  • 103 views
  • 23 Jan, 2021
  • +79 other locations
Venetoclax Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma

Phase I/II trial, with the aim of evaluating the efficacy of venetoclax to the backbone of rituximab-lenalidomide in patients with relapsed/refractory MCL.

Department of Hematology Aarhus University Hospital
 (1.2 away) Contact site
  • 3 views
  • 26 Jan, 2021
  • +21 other locations
A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barr Syndrome (GBS)

This study is a multi center, open-label, study of ANX005 in combination with IVIg in subjects diagnosed with GBS.

Aarhus University Hospital
 (1.2 away) Contact site
  • 10 views
  • 30 Jan, 2021
  • +9 other locations
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab Followed by Maintenance Durvalumab Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients.

This is a Phase III randomised, double-blind, multi-centre study to evaluate the efficacy and safety of durvalumab in combination with standard of care platinum based chemotherapy and bevacizumab followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian cancer.

Research Site
 (4.0 away) Contact site
  • 84 views
  • 16 May, 2021
  • +286 other locations
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary arterial hypertension (PAH) compared to macitentan 10 mg.

macitentan
ventricular septal defect
hemodynamic evaluation
left ventricular end-diastolic pressure
hypertension
rhus Universitetshospital, Skejby, Hjertemedicinsk Afdeling B
 (4.0 away) Contact site
  • 37 views
  • 21 May, 2021
  • +262 other locations